News | August 27, 2022
Benvic acquires specialty U.S. compounder Chemres
The ninth acquisition since 2018
The ninth acquisition since 2018
Lutio has the potential to offer significant cost savings when available to UK patients.
The company has received 1 (ONE) observation on Form 483 with respect to ANDA filed for the product to be manufactured at the said Facility.
This Bioforum will provide the latest insights on delivering increased speed, greater flexibility and enhanced quality while reducing the cost, and risks of navigating the evolving biopharma landscape
The initiative aims to reach out to more than 20 million people across the country and a number of social media influencers have also pledged to extend their whole-hearted support for the noble cause
JB Pharma is the fastest growing pharmaceutical company in FY 2021-22 and Q1 of FY 2022-23.
99% of Pristyn Doctors are using EMR facility on its doctor app
Formoterol Fumarate Inhalation Solution (RLD Perforomist) had estimated annual sales of US $282 million in the US
The cash consideration for the above acquisition will be Euro 26 million.
Subscribe To Our Newsletter & Stay Updated
